The Mumbai R&D facility has an experienced team of 28 scientists including 8 Ph.Ds dedicated to innovation in new product development, cost optimization, and novel route scouting projects for generic APIs. The R&D team develops novel/non-infringing process for APIs and is supported by state-of-the-art, best in class, analytical research capabilities.
Piramal Enterprises Limited , A-Wing, Lighthall Building, Sakinaka, Sakivihar Road, Andheri -East, Mumbai – 400072
- Development of environmental friendly processes
- Development of chiral APIs
- Ability to comply with ICH guidelines
- Synthesis, Isolation and characterization of impurities
- Expertise in handling pyrophoric reagent
- Expertise in cryogenic reactions (-40 to -100°C)
- Expertise in handling organometallic reactions
Generic API business
Our Generic API business partners with pharmaceutical companies across the globe and supplies generic APIs to more than 60 countries across the globe. The site has filed more than 10 APIs and has 2 APIs under development. The APIs developed at this site are then manufactured at manufacturing sites in our network inspected by various regulatory authorities including US FDA, UK MHRA, PMDA Japan, and ANVISA among others. The site boasts of a strong regulatory team with knowledge of filing in various countries/geographies.